van Es La
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Immunology 22
- Complement system in diseases 12
- Immunodeficiency and Autoimmune Disorders 5
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Daha Mr (29 shared papers)S. Lobatto (2 shared papers)K. Andrássy (1 shared paper)Johan W. de Fijter (2 shared papers)Patricia M. Schulte (1 shared paper)Reid S. Brennan (1 shared paper)Andrew Whitehead (1 shared paper)Liesbeth E. Jonges (1 shared paper)
- Journals
- Biophysical Journal (1 paper)Molecular Biology and Evolution (1 paper)Clinical & Experimental Immunology (1 paper)PLoS Biology (1 paper)PubMed (43 papers)
- Partner nations
- NetherlandsUnited StatesSouth Africa
In The Last Decade
van Es La
44 papers receiving 563 citations
Peers
Comparison fields: 5 of 79
- Nephrology 174
- Transplantation 50
- Immunology 237
- Hematology 107
- Rheumatology 100
Countries citing papers authored by van Es La
This map shows the geographic impact of van Es La's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van Es La with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van Es La more than expected).
Fields of papers citing papers by van Es La
This network shows the impact of papers produced by van Es La. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van Es La. The network helps show where van Es La may publish in the future.
Co-authors
The 25 scholars most cited alongside van Es La, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. | 1995 | 69 |
| 2 | Blood group B antigen on renal endothelium as the target for rejection in an ABO-incompatible recipient. | 1978 | 48 |
| 3 | Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees. | 1987 | 41 |
| 4 | 2018 | 38 | |
| 5 | The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. | 1990 | 38 |
| 6 | Studies on the lability of hypertension in man. | 1968 | 38 |
| 7 | Further evidence for the antibody nature of C3 nephritic factor (C3NeF). | 1979 | 36 |
| 8 | Histomorphometric correlates of renal failure in IgA nephropathy. | 1998 | 33 |
| 9 | IgA antibodies directed against cytoplasmic antigens of polymorphonuclear leukocytes in patients with Henoch-Schoenlein purpura. | 1987 | 30 |
| 10 | Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor. | 1982 | 27 |
| 11 | Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. | 1981 | 25 |
| 12 | The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages. | 1982 | 20 |
| 13 | Systemic capillary leak syndrome. Preventive treatment with terbutaline. | 1988 | 18 |
| 14 | Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement. | 1981 | 15 |
| 15 | Recurrence of IgA nephropathy after renal transplantation. | 1999 | 14 |
| 16 | Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. | 1979 | 13 |
| 17 | Complement depletion abolishes IgA-mediated glomerular inflammation in rats. | 1994 | 10 |
| 18 | Long term follow-up of living kidney donors. A two-centre study. | 1985 | 9 |
| 19 | Soluble oligovalent antigen--antibody complexes. II. The effect of various selective forces upon relative stability of isolated complexes. | 1979 | 9 |
| 20 | The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes. | 1983 | 8 |
About van Es La
van Es La is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Nephrology, Molecular Biology and Hematology, having authored 47 papers that have together received 644 indexed citations. Recurring topics across this work include Complement system in diseases (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Blood groups and transfusion (9 papers), Renal Diseases and Glomerulopathies (9 papers), Vasculitis and related conditions (6 papers), Renal Transplantation Outcomes and Treatments (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). The work is most often cited by research in Nephrology (174 citations), Transplantation (50 citations), Immunology (237 citations), Hematology (107 citations) and Rheumatology (100 citations) van Es La has collaborated with scholars based in Netherlands, United States and South Africa. Frequent co-authors include Daha Mr, S. Lobatto, K. Andrássy, Johan W. de Fijter, Patricia M. Schulte, Reid S. Brennan, Andrew Whitehead, Liesbeth E. Jonges, Timothy M. Healy and Aize Kijlstra. Their work appears in journals such as Biophysical Journal, Molecular Biology and Evolution, Clinical & Experimental Immunology, PLoS Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.